Filing Flows › Outset Medical (OM) › R&D spending
Outset Medical (OM) R&D spending by quarter
Outset Medical's R&D spending was $5.9M in Q3 2026 (third quarter 2026), +8% from Q2 2026. Over the last 7 quarters it ranged from $5.1M (Q4 2025) to $5.9M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $5.9M | +8% | +10% |
| Q2 2026 | $5.5M | -3% | +3% |
| Q1 2026 | $5.6M | +11% | +2% |
| Q4 2025 | $5.1M | -6% | — |
| Q3 2025 | $5.4M | +2% | — |
| Q2 2025 | $5.3M | -4% | — |
| Q1 2025 | $5.5M | — | — |
Q3 2026 at a glance
Outset Medical, Q3 2026: revenue $33.6M (+14% year over year), operating margin -36.5%, net loss $14.7M, operating cash flow −$10.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Outset Medical's R&D spending?
Outset Medical's R&D spending was $5.9M in Q3 2026 (third quarter 2026), +8% from Q2 2026.
How has Outset Medical's R&D spending changed?
Over the last 7 quarters it ranged from $5.1M (Q4 2025) to $5.9M (Q3 2026).